How to buy Cronos shares | $5.24
Own Cronos shares in just a few minutes.
Cronos Group Inc is a drug manufacturers—specialty & generic business with stocks listed in the US. Cronos shares (CRON) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$5.24 – an increase of 0.58% over the previous week.
How to buy shares in Cronos
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Cronos. Find the share by name or ticker symbol: CRON. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cronos reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$5.24, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Cronos, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Cronos. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
How has coronavirus impacted Cronos's share price?
Since the stock market crash in March caused by coronavirus, Cronos's share price has had significant negative movement.
Its last market close was US$5.24, which is 26.71% down on its pre-crash value of US$7.15 and 31.00% up on the lowest point reached during the March crash when the shares fell as low as US$4.
If you had bought US$1,000 worth of Cronos shares at the start of February 2020, those shares would have been worth US$718.08 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth US$734.91.
Cronos share priceUse our graph to track the performance of CRON stocks over time.
Cronos shares at a glance
|Latest market close||USD$5.24|
|52-week range||USD$4.43 - USD$11.77|
|50-day moving average||USD$5.8071|
|200-day moving average||USD$6.0021|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.952|
Standard brokerage - US shares
Get $0 brokerage on US stocks with trades as little as $50 when you join the world’s biggest social trading network.
- $0 brokerage for US stocks
- Trades starting from $50
- Fractional shares
- Copy top traders
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy Cronos stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Cronos price performance over time
|1 week (2020-09-11)||0.58%|
|1 month (2020-08-18)||-4.90%|
|3 months (2020-06-18)||-20.12%|
|6 months (2020-03-18)||-8.23%|
|1 year (2019-09-18)||-52.19%|
|2 years (2018-09-18)||-54.67%|
|3 years (2017-09-18)||143.72%|
|5 years (2015-09-14)||N/A|
Is Cronos under- or over-valued?
Valuing Cronos stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cronos's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cronos's P/E ratio
Cronos's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Cronos shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||US$31.4 million|
|Gross profit TTM||US$-15,964,000|
|Return on assets TTM||-5.46%|
|Return on equity TTM||48.76%|
|Market capitalisation||US$1.8 billion|
TTM: trailing 12 months
Shorting Cronos shares
There are currently 45.7 million Cronos shares held short by investors – that's known as Cronos's "short interest". This figure is 4.8% down from 48.0 million last month.
There are a few different ways that this level of interest in shorting Cronos shares can be evaluated.
Cronos's "short interest ratio" (SIR)
Cronos's "short interest ratio" (SIR) is the quantity of Cronos shares currently shorted divided by the average quantity of Cronos shares traded daily (recently around 3.6 million). Cronos's SIR currently stands at 12.7. In other words for every 100,000 Cronos shares traded daily on the market, roughly 12700 shares are currently held short.
However Cronos's short interest can also be evaluated against the total number of Cronos shares, or, against the total number of tradable Cronos shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cronos's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 Cronos shares in existence, roughly 140 shares are currently held short) or 0.2722% of the tradable shares (for every 100,000 tradable Cronos shares, roughly 272 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Cronos.
Find out more about how you can short Cronos stock.
Cronos share dividends
We're not expecting Cronos to pay a dividend over the next 12 months.
Cronos share price volatility
Over the last 12 months, Cronos's shares have ranged in value from as little as US$4.43 up to US$11.77. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cronos's is 1.7776. This would suggest that Cronos's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.
Frequently asked questions
Ask an Expert